Clinical Trial Update: A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of MEBO Wound Ointment in diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• MEBO Wound Ointment

Snippet

Sponsor: Skingenix, Inc. | Conditions: Diabetic Foot Ulcers | Phase 2 | Status: COMPLETED